Soluble siglec5: A new prognosis marker in colorectal cancer patients

9Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Colorectal cancer (CRC) is the second most deadly and third most commonly diagnosed cancer worldwide. There is significant heterogeneity among patients with CRC, which hinders the search for a standard approach for the detection of this disease. Therefore, the identification of ro-bust prognostic markers for patients with CRC represents an urgent clinical need. In search of such biomarkers, a total of 114 patients with colorectal cancer and 67 healthy participants were studied. Soluble SIGLEC5 (sSIGLEC5) levels were higher in plasma from patients with CRC compared with healthy volunteers. Additionally, sSIGLEC5 levels were higher in exitus than in survivors, and the receiver operating characteristic curve analysis revealed sSIGLEC5 to be an exitus predictor (area under the curve 0.853; cut‐off > 412.6 ng/mL) in these patients. A Kaplan–Meier analysis showed that patients with high levels of sSIGLEC5 had significantly shorter overall survival (hazard ratio 15.68; 95% CI 4.571–53.81; p ≤ 0.0001) than those with lower sSIGLEC5 levels. Our study suggests that sSIGLEC5 is a soluble prognosis marker and exitus predictor in CRC.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

75829Citations
N/AReaders
Get full text

The blockade of immune checkpoints in cancer immunotherapy

11047Citations
N/AReaders
Get full text

Signatures of mutational processes in human cancer

7488Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Siglecs as therapeutic targets in cancer

35Citations
N/AReaders
Get full text

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer

20Citations
N/AReaders
Get full text

The prognostic impact of SIGLEC5-induced impairment of CD8<sup>+</sup> T cell activation in sepsis

19Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Montalbán‐hernández, K., Cantero‐cid, R., Lozano‐rodríguez, R., Pascual‐iglesias, A., Avendaño‐ortiz, J., Casalvilla‐dueñas, J. C., … Collazo, E. L. (2021). Soluble siglec5: A new prognosis marker in colorectal cancer patients. Cancers, 13(15). https://doi.org/10.3390/cancers13153896

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

50%

Researcher 2

50%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 2

33%

Immunology and Microbiology 2

33%

Chemistry 1

17%

Nursing and Health Professions 1

17%

Save time finding and organizing research with Mendeley

Sign up for free